Skip to playerSkip to main content
  • 7 months ago
Health leaders say evidence on the benefits and risks of the treatment for teenagers is limited. Young people already receiving prescriptions will continue care while guidance is reviewed.

Category

🗞
News
Transcript
00:00NHS England has paused new prescriptions of cross-sex hormones for 16 and 17-year-olds
00:06questioning their gender. The move follows evidence review commissioned after the independent
00:12CAS report into Children's Gender Services. Health officials say the research on benefits
00:18and risks of the treatment is limited. New prescriptions will pause while longer-term
00:24guidance is considered. Teenagers already receiving hormones will continue treatment,
00:29but clinicians will review their care. An advocacy group for transgender people says it is considering
00:35legal action over the decision. NHS England says other support remains available through
00:40gender services for young people and their families.

Recommended